[/(
Cortisone-resistant/JJ
bronchial/JJ
asthma/NN
]/)

There/EX
is/VBZ
general/JJ
agreement/NN
on/IN
the/DT
inflammatory/JJ
pathogenesis/NN
of/IN
bronchial/JJ
asthma/NN
:/:
an/DT
accumulation/NN
of/IN
activated/VBN
eosinophils/NNS
,/,
degranulated/VBN
mast/NN
cells/NNS
,/,
T/NN
lymphocytes/NNS
and/CC
in/IN
very/RB
severe/JJ
forms/NNS
,/,
granulocytes/NNS
has/VBZ
constantly/RB
been/VBN
found/VBN
in/IN
the/DT
bronchial/JJ
mucosa/NN
./.
=====
In/IN
allergic/JJ
bronchial/JJ
asthma/NN
,/,
inflammation/NN
seems/VBZ
to/TO
be/VB
orchestrated/VBN
predominantly/RB
by/IN
a/DT
subset/NN
of/IN
T/NN
lymphocytes/NNS
,/,
with/IN
a/DT
phenotype/NN
similar/JJ
to/TO
the/DT
Th2/NN
subset/NN
able/JJ
to/TO
produce/VB
IL-4/NN
and/CC
IL-5/NN
./.
=====
Although/IN
corticosteroids/NNS
are/VBP
the/DT
most/RBS
potent/JJ
therapeutic/JJ
agents/NNS
used/VBN
for/IN
this/DT
disease/NN
,/,
their/PRP$
anti-inflammatory/JJ
effect/NN
differs/VBZ
from/IN
patient/NN
to/TO
patient/NN
./.
=====
Some/DT
criteria/NNS
which/WDT
can/MD
be/VB
used/VBN
to/TO
define/VB
steroid-resistant/JJ
bronchial/JJ
asthma/NN
are/VBP
listed/VBN
here/RB
./.
=====
This/DT
review/NN
analyzes/VBZ
various/JJ
molecular/JJ
alterations/NNS
responsible/JJ
for/IN
the/DT
deficient/JJ
response/NN
to/TO
corticosteroid/NN
treatment/NN
observed/VBN
in/IN
steroid-resistant/JJ
bronchial/JJ
asthmatic/JJ
subjects/NNS
./.
=====
New/JJ
knowledge/NN
on/IN
the/DT
mechanism/NN
of/IN
steroid/NN
resistance/NN
may/MD
have/VB
important/JJ
implications/NNS
for/IN
the/DT
treatment/NN
of/IN
chronic/JJ
asthma/NN
and/CC
other/JJ
diseases/NNS
./.